As the world’s first airport to attain the full suite of Center of Excellence for Independent Validators (CEIV) certifications from the International Air Transport Association’s (IATA) for the handling of special cargo Hong Kong International Airport (HKIA) is committed to continue reinforcing our operations excellence and to unlock the full potential of Hong Kong’s air cargo through industry collaborations.   

Since 2023, HKIA has established a collaboration on Corridor 3.0 Project with Miami International Airport, Pharma.Aero and Cathay Cargo, and proudly announced the successful validation of the Hong Kong-Miami pharmaceutical air corridor in November 2024. The latest initiative builds on the achievements of Pharma.Aero projects Corridor 1.0, established in 2020 between HKIA and Brussels Airport for validation of secure handling process and visibility in the supply chain, and Corridor 2.0 with proven Template Protocol, to validate the route between HKIA and Miami International Airport specifically for secure and temperature-controlled airport-to-airport transportation of pharmaceutical products.  

A blue truck with a white container AI-generated content may be incorrect.

A white box on a yellow platform AI-generated content may be incorrect.

The Corridor 3.0 Project’s validation result demonstrates 100% success rate, with zero temperature excursions and no shipment failures, establishing the reliable and high-quality airport-to-airport pharmaceutical corridor between Miami and Hong Kong. “As the pioneer airport in formulating and launching the airport-to-airport pharma corridor, Hong Kong International Airport (HKIA) now continues to take the lead in Pharma Corridor 3.0 to enable live pharma shipments in transit between Miami and Hong Kong. This is another successful showcase to demonstrate the community collaborative efforts and HKIA commitment on operations excellence in handling temperature sensitive cargo.” said Cissy Chan, Executive Director, Commercial, at Airport Authority Hong Kong. “Together with our strategic location, advanced infrastructure, and high service quality assurance, HKIA is an ideal gateway for pharmaceutical companies.” 

For more information regarding the collaborative initiative, please refer to the white paper of Pharma.Aero Corridor 3.0 Hong Kong - Miami .